G-Protein Coupled Receptors Industry Outlook 2025-2029: Market Set to Cross $4.46 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the G-Protein Coupled Receptors Market Size By 2025?
In recent times, the market size of G-protein coupled receptors has witnessed a robust growth. The projection is that it will expand from $3.2 billion in 2024, to reach $3.41 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.6%. Several factors have contributed to this growth during the historic period, including drug discovery advancements, FDA approvals, genomic discoveries, emerging markets, market consolidation, and an increasing aging population.

How Big Is the G-Protein Coupled Receptors Market Size Expected to Grow by 2029?
The market size for G-protein coupled receptors is predicted to experience robust expansion in the coming years. The estimation is that it will soar to $4.46 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%. The accelerated growth in the projection period can be credited to the rise of personalized medicine, heightened emphasis on uncommon diseases, the utilization of artificial intelligence in drug discovery, the focus on patient-driven drug development, contextual and social factors, as well as the surge in the biosimilar market. Top trends in the forecast timeframe encompass advancements in biotechnology, amplified investment in research and development, technological revolutions, alliances and partnerships, along with digital therapeutics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

Which Key Market Drivers Powering G-Protein Coupled Receptors Market Expansion and Growth?
The surge in cancer cases is anticipated to boost the expansion of the G-protein-coupled receptors market. Cancer is a disease where abnormal cells can invade surrounding tissues and proliferate uncontrollably. The lymphatic and vascular systems offer additional pathways for the spread of cancer cells. GPCRs regulate the processes that are identified as the distinct elements of cancer, such as proliferative signaling, replicative immortality, growth suppressor evasion, resistance to cell death, and initiation of invasion and metastasis. For example, in January 2023, the American Cancer Society, a US-based professional organization, stated that there were 1,958,310 new cancer diagnoses in the US in 2023, which is higher than the projected 1.9 million new cases in 2022. Consequently, the augmenting incidence of cancer is fueling the boom in the G-protein coupled receptors market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the G-Protein Coupled Receptors Market?
One notable trend gaining traction in the G-protein-coupled receptor (GPCR) market is the increasing investment in enhancing GPCR screening and antibody-related development. Major players in the GPCR sector are keen on securing investment to further the progress of drug and medication technologies pertinent to GPCR-related conditions. For instance, in February 2023, a UK-based venture capital company, LifeArc Ventures, made a financial commitment of $16 million to Maxion Therapeutics, a British drug discovery firm, to improve the production of antibodies for previously incurable ion channel and GPCR-related disorders. This investment will facilitate the creation of antibody therapeutics aimed at ion channels and G-protein-coupled receptors (GPCRs) leveraging the unique KnotBody technology. This technology allows the identification of biologicals against ion channels and GPCRs through the use of naturally existing cysteine-rich mini proteins. In another development, a US-based biotech firm, Septerna Inc., has confirmed its launch and Series A financing of $100 million. This investment will be utilized to advance their nascent pipeline of cutting-edge GPCR-focused medication programs, facilitated by the Native Complex Platform, spanning several therapeutic areas.

What Are the Emerging Segments in the G-Protein Coupled Receptors Market?
The G-protein coupled receptors market covered in this report is segmented -

1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands
2) By Assay: CAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding And GTPγS Functional Assays, Internalization Assays, Trafficking Assays
3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

Subsegments:
1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines
2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays
3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors
4) By Ligands: Agonists, Antagonists, Inverse Agonists

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11976&type=smp

Who Are the Global Leaders in the G-Protein Coupled Receptors Market?
Major companies operating in the G-protein coupled receptors market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna

Which are the Top Profitable Regional Markets for the G-Protein Coupled Receptors Industry?
North America was the largest region in the G-protein coupled receptors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the G-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11976

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.